Table I.
Baseline characteristics
| Parameter | SYNTAX score ≤ 22 (n = 172) | SYNTAX score > 22 (n = 96) | Value of p |
|---|---|---|---|
| Age, mean ± SD [years] | 57.8 ±10.5 | 61.7 ±11.4 | 0.005 |
| Male, n (%) | 91 (53) | 63 (66) | 0.043 |
| BMI, mean ± SD [kg/m2] | 27.4 ±3.6 | 27.5 ±2.6 | 0.903 |
| Family history, n (%) | 102 (59) | 71 (74) | 0.016 |
| Smoking, n (%) | 77 (45) | 58 (60) | 0.014 |
| Hypertension, n (%) | 95 (55.2) | 68 (71) | 0.060 |
| Diabetes, n (%) | 33 (19) | 30 (31) | 0.026 |
| LDL-C, mean ± SD [mg/dl] | 110.8 ±30.1 | 122.9 ±35.2 | < 0.001 |
| HDL-C, mean ± SD [mg/dl] | 46.7 ±8.6 | 44.7 ±8.2 | 0.058 |
| TG, mean ± SD [mg/dl] | 144.8 ±41.2 | 152.1 ±55.1 | 0.220 |
| Fasting blood glucose, mean ± SD [mg/dl] | 110.7 ±25.3 | 121.8 ±23.4 | < 0.001 |
| CrCl, mean ± SD [ml/min] | 101.1 +30.8 | 92.7 ±31.9 | 0.035 |
| CRP, mean ± SD [mg/dl] | 0.84 ±1.2 | 1.69 ±2.2 | < 0.001 |
| RF, mean ± SD [IU/ml] | 11.36 ±5 | 16.4 ±9 | < 0.001 |
| RF positive (> 20 IU/ml), n (%) | 12 (7) | 38 (40) | < 0.001 |
| ACE-inh/ARB use, n (%) | 97 (56.4) | 63 (65.6) | 0.140 |
| Statin use, n (%) | 43 (25) | 30 (32.3) | 0.270 |
| β-Blocker use, n (%) | 104 (60) | 62 (64.6) | 0.506 |
| Ca+ + channel blocker use, n (%) | 28 (16.3) | 15 (15.6) | 0.889 |